Read More

Sanara MedTech Inc. Announces The Publication of A 5,335 Patient Study Demonstrating A Significant Reduction In Surgical Site Infections When Activated Collagen (CellerateRX Surgical Powder) Was Used To Promote Wound Healing

Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ:SMTI), a medical technology company focused on developing and commercializing transformative

SMTI

Read More

A Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen, Patented Nicotinamide Riboside, Supplementation Induces A Potent NAD+ Response And Is Associated With Mild Improvement In Parkinson’s Disease

Building on a growing body of research showcasing NR as a potential therapeutic strategy for PD, this is the first clinical study to showcase the safety, tolerability, and beneficial metabolic effects of high-dose NR at

CDXC